Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
Author:
- 16 August 2010
- journal article
- review article
- Published by Wiley in Journal of Diabetes
- Vol. 2 (3) , 146-156
Abstract
Observations from clinical studies suggest that low serum levels of testosterone in men are often associated with obesity, insulin resistance, and metabolic compromise. Indeed, the clinical symptoms of late‐onset hypogonadism are markedly similar to those of Type 2 diabetes mellitus (T2DM) and metabolic syndrome, and may share a similar pathophysiology. Observational and experimental data suggest that testosterone treatment improves a number of hallmark features of T2DM and metabolic syndrome, namely insulin resistance, obesity, dyslipidemia, and sexual dysfunction. Consequently, clinical studies have been undertaken to assess the impact of testosterone‐replacement therapy in this patient group. The present article reviews the observational clinical data suggesting an association between low serum testosterone and metabolic impairment, the clinical data relating to the effects of testosterone treatment on components of the metabolic syndrome, and the randomized clinical trails that have formally investigated whether testosterone‐replacement therapy provides clinical benefit to hypogonadal men with T2DM and/or metabolic syndrome.Keywords
This publication has 67 references indexed in Scilit:
- Fifty‐ two—Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma TestosteroneJournal of Andrology, 2009
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA RecommendationsJournal of Andrology, 2009
- Testosterone Concentration in Young Patients With DiabetesDiabetes Care, 2008
- A Dose‐Response Study of Testosterone on Sexual Dysfunction and Features of the Metabolic Syndrome Using Testosterone Gel and Parenteral Testosterone UndecanoateJournal of Andrology, 2008
- The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetesEuropean Journal of Endocrinology, 2007
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006
- The hypogonadal–obesity cycle: role of aromatase in modulating the testosterone–estradiol shunt – a major factor in the genesis of morbid obesityMedical Hypotheses, 1999
- Effect of Testosterone Replacement on Whole Body Glucose Utilisation and Other Cardiovascular Risk Factors in Males with Idiopathic Hypogonadotrophic HypogonadismHormone and Metabolic Research, 1998
- Beneficial Effects of Testosterone Undecanoate on the Lipoprotein Profiles in Healthy Elderly Men. A Placebo Controlled Study.Japanese Heart Journal, 1997
- Testosterone and Regional Fat DistributionObesity Research, 1995